85094-1
LOINC Code
| LOINC code | 85094-1 | ||||||
|---|---|---|---|---|---|---|---|
| name | |||||||
| description | This panel includes quantitative results for escitalopram and its major metabolite, norescitalopram, in serum or plasma to monitor liver toxicity and adjust dosage as needed. Escitalopram is used to treat patients with a major depressive disorder, generalized anxiety disorder, social anxiety disorder, or panic disorder. | ||||||
| status | ACTIVE | ||||||
Fully-Specified Name | |||||||
| component | Escitalopram & norescitalopram panel | ||||||
| property | - | ||||||
| time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||||||
| system | Ser/Plas Ser = Serum Plas = Plasma | ||||||
| scale | - | ||||||
| method | |||||||
Additional Names | |||||||
| short name | Cipralex; DRUG/TOXICOLOGY; Drugs; Escitalopram + norescitalo Pnl; Escitalopram+norescitalopram; Lexamil; Lexapro; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR | ||||||
Basic Attributes | |||||||
| class | PANEL.DRUG/TOX | ||||||
| type | 1 Laboratory | ||||||
| order vs. observation | Escitalopram + | ||||||
Panel Components | |||||||
| |||||||
History/Usage | |||||||
| first released | |||||||
| last updated | 2.58 | ||||||
| last change type | ADD - added | ||||||
Related Names | |||||||
Copyright © 2026 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2026, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com